SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-020880
Filing Date
2022-08-01
Accepted
2022-08-01 16:10:17
Documents
1
Period of Report
2022-08-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3729
  Complete submission text file 0001493152-22-020880.txt   5169
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Issuer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121
Business Address
Gross Jane A (Reporting) CIK: 0001684258 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40101 | Film No.: 221124822